Skip to main content
Conan G. Kinsey
( out of 219 reviews )

Conan G. Kinsey, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
1950 Circle of Hope
Salt Lake City , UT 84112

Dr. Conan Kinsey, MD, PhD

Assistant Professor

Dr. Kinsey is from Lancaster, Pennsylvania and completed his undergraduate education at Bucknell University in Lewisburg, Pennsylvania. He then went on to train in the Medical Scientist Training Program at the University of Rochester School of Medicine and Dentistry in Rochester, New York completing his Ph.D. in Genetics in Hartmut Land’s Laboratory and his M.D. He completed a Research Track Internal Medicine Residency at the University of Utah and a Medical Oncology Fellowship at the Huntsman Cancer Institute with a post-doctoral fellowship in Martin McMahon's Laboratory. Dr. Kinsey specializes in Gastrointestinal Oncology with a translational research focus on pancreatic cancer.

Board Certification

American Board of Internal Medicine
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Medical Oncology)

Patient Rating

Patients consistently praise Dr. Kinsey for clear, easy-to-understand explanations and for listening closely to their concerns. Reviewers highlight his caring, personable bedside manner, and that he spends ample time to make appointments comfortable. Many also note his strong clinical knowledge, preparation, responsiveness, and collaborative approach with other members of the care team, expressing high trust in his recommendations.

Generated via Patient Reviews

5.0 /5
( out of 219 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


Apr 25, 2026
HUNTSMAN CANCER CENTER

Dr. Kinsey is the absolute best. He is genuine and sincere and has the best bed side manner of any doctor I have ever experienced. He's very patient and I have never felt rushed. I can't say enough good things about him.

Apr 24, 2026
HUNTSMAN CANCER CENTER

Very good Dr

Feb 21, 2026
HUNTSMAN CANCER CENTER

He has a wonderful bedside manner and he only wants the best for me.

Feb 03, 2026
HUNTSMAN CANCER CENTER

Always explains things so I understand it. And asks and listens to my input and concerns

Jan 24, 2026
HUNTSMAN CANCER CENTER

Dr Kinsey is very caring and awesome!

Dec 13, 2025
HUNTSMAN CANCER CENTER

Dr. Kinsey is very professional and a terrific physician . My care has been excellent.

Dec 12, 2025
HUNTSMAN CANCER CENTER

He is great and spends as much time as you need

Sep 18, 2025
HUNTSMAN CANCER CENTER

Dr. Kinsey is the best, always listens, helpful, knowledgeable, and truly cares.

Aug 15, 2025
HUNTSMAN CANCER CENTER

Dr Kinsey is the best

Jul 19, 2025
HUNTSMAN CANCER CENTER

Very knowledgeable very caring listens to you

May 24, 2025
HUNTSMAN CANCER CENTER

Always takes the time to explain things, and makes sure I understand.

May 10, 2025
HUNTSMAN CANCER CENTER

Very easy to talk to and makes the appointment comfortable for me.

May 04, 2025
HUNTSMAN CANCER CENTER

Great bedside!

Apr 26, 2025
HUNTSMAN CANCER CENTER

Very good at listening to your concerns, and explaining processes. Always speaks respectfully to you. Very personable.

Apr 04, 2025
HUNTSMAN CANCER CENTER

Very knowledgeable and caring

Nov 09, 2024
HUNTSMAN CANCER CENTER

thank you

Oct 17, 2024
HUNTSMAN CANCER CENTER

Dr. Kinsey is the best! He works well with my medical team, is very responsive and cooperative. Not only does he listen to my concerns but his explanations are easy to understand and relatable. I just love him!!!!


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor
Oncological Sciences -Adjunct Assistant Professor
Academic Divisions Oncology
Board Certification
American Board of Internal Medicine
American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Medical Oncology)

Education history

Postdoctoral Fellowship Hematology/Oncology - Huntsman Cancer Institute Postdoctoral Fellow
Fellowship Hematology/Oncology - Huntsman Cancer Institute Fellow
Residency Internal Medicine - University of Utah School of Medicine Resident
Professional Medical Genetics and Medicine - University of Rochester School of Medicine and Dentistry M.D., Ph.D.
Undergraduate Cell Biology/Biochemistry - Bucknell University B.S.

Selected Publications

Journal Article

  1. Foth M, Kim W, OToole K, Murphy B, Justo-Garrido M, Boggaram S, Ghazi P, Brennan E, Wright MI, Shepherd T, Cortes-Sanchez E, Wang Y, Roth JA, Rees MG, Ronan MM, Jiang J, Wasko UN, Jiang A, Becker C, Deacon DC, Holmen SL, VanBrocklin MW, Hu-Lieskovan S, Kinsey CG, Russell JS, Hegde A, Garrido-Laguna I, Holderfield M, Singh M, McMahon M (2026). Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma. Cancer Res.
  2. Dacheux MA, Wu MJ, Scherzer MT, Nillson M, Murphy B, Schuman S, Ju Z, Bivona T, Lito P, Gumbleton M, Puri S, Akerley W, Wang J, Wang K, Heymach J, Kinsey CG, Negrao M, McMahon M, Vaishnavi A (2025). BRAF(V600E)-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling. bioRxiv.
  3. Ghazi PC, OToole KT, Srinivas Boggaram S, Scherzer MT, Silvis MR, Zhang Y, Bogdan M, Smith BD, Lozano G, Flynn DL, Snyder EL, Kinsey CG, McMahon M (2024). Inhibition of ULK1/2 and KRAS(G12C) controls tumor growth in preclinical models of lung cancer. Elife, 13.
  4. Vaishnavi A, Juan J, Jacob M, Stehn C, Gardner EE, Scherzer MT, Schuman S, Van Veen JE, Murphy B, Hackett CS, Dupuy AJ, Chmura SA, van der Weyden L, Newberg JY, Liu A, Mann K, Rust AG, Weiss WA, Kinsey CG, Adams DJ, Grossmann A, Mann MB, McMahon M (2021). Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven Lung Tumorigenesis. Cancer Res, 82(22), 4261-4273.
  5. Truong A, Yoo JH, Scherzer MT, Sanchez JMS, Dale KJ, Kinsey CG, Richards JR, Shin D, Ghazi PC, Onken MD, Blumer KJ, Odelberg SJ, McMahon M (2020). Chloroquine Sensitizes GNAQ/11-mutated Melanoma to MEK1/2 Inhibition. Clin Cancer Res, 26(23), 6374-6386.
  6. Vaishnavi A, Scherzer MT, Kinsey CG, Parkman GL, Truong A, Ghazi P, Schuman S, Battistone B, Garrido-Laguna I, McMahon M (2019). Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven Cancer. Cell Rep, 32(5), 107994.
  7. Kinsey C, Balakrishnan V, ODell MR, Huang JL, Newman L, Whitney-Miller CL, Hezel AF, Land H (2014). Plac8 links oncogenic mutations to regulation of autophagy and is critical to pancreatic cancer progression. Cell Rep, 7(4), 1143-55.
  8. McMurray HR, Sampson ER, Compitello G, Kinsey C, Newman L, Smith B, Chen SR, Klebanov L, Salzman P, Yakovlev A, Land H (2008). Synergistic response to oncogenic mutations defines gene class critical to cancer phenotype. Nature, 453(7198), 1112-6.
  9. Kinsey CG, Bussolati G, Bosco M, Kimura T, Pizzorno MC, Chernin MI, Cassoni P, Novak JF (2007). Constitutive and ligand-induced nuclear localization of oxytocin receptor. J Cell Mol Med, 11(1), 96-110.
  10. Takahashi M, Chernin MI, Yamamoto O, Tonzetich J, Kinsey CG, Novak JF (2002). Transformation of MC3T3-E1 cells following stress and transfection with pSV2neo plasmid. Anticancer Res, 22(2A), 585-98.

Review

  1. Foth M, Garrido-Laguna I, Kinsey CG (2021). Therapeutic Targeting of Autophagy in Pancreatic Cancer. [Review]. Surg Oncol Clin N Am, 30(4), 709-718.
  2. Gajiwala S, Torgeson A, Garrido-Laguna I, Kinsey C, Lloyd S (2018). Combination immunotherapy and radiation therapy strategies for pancreatic cancer-targeting multiple steps in the cancer immunity cycle. [Review]. J Gastrointest Oncol, 9(6), 1014-1026.

Book Chapter

  1. Vaishnavi A, Kinsey CG, McMahon M (2023). Preclinical Modeling of Pathway-Targeted Therapy of Human Lung Cancer in the Mouse. In Cold Spring Harb Perspect Med. United States.
  2. Gilcrease GW, Kinsey C, Stenehjem D (2015). Environmental and genetic risk factors in hepatocellular carcinoma. In Torre A, Uscanga L (Eds.), Medicina Individualizada De La Evidencia A La Práctica Clínica (pp. 155-62). Permanyer México.

Research Lab

Lab link